<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26679744</PMID><DateCompleted><Year>2016</Year><Month>11</Month><Day>01</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>5</Volume><PubDate><Year>2015</Year><Month>Dec</Month><Day>18</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>A functional polymorphism in IFNAR1 gene is associated with susceptibility and severity of HFMD with EV71 infection.</ArticleTitle><Pagination><StartPage>18541</StartPage><MedlinePgn>18541</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">18541</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/srep18541</ELocationID><Abstract><AbstractText>Enterovirus 71 (EV71), one of the major pathogens of Hand, foot and mouth disease (HFMD), results in millions of infections and hundreds of deaths each year in Southeast Asia. Biased infection and variable clinical manifestations of EV71 HFMD indicated that host genetic background played an important role in the occurrence and development of the disease. We identified the mRNA profiles of EV71 HFMD patients, which type I interferon (IFN) pathway related genes were down-regulated. Four single nucleotide polymorphisms (SNPs) of type I IFN receptor 1 (IFNAR1) were chosen to analyze their relationships to EV71 infection. We found that genotype GG of promoter variant rs2843710 was associated with the susceptibility and severity to EV71 HFMD. In addition, we assessed the regulatory effects of rs2843710 to IFN stimulated genes (ISGs), and found that the expressions of IFNAR1, OAS1 and MX1 were significantly lower in patients with rs2843710 genotype GG. And rs2843710 allele G showed weaker transcriptional activity compared with allele C. Our study indicated that rs2843710 of IFNAR1 was associated with the susceptibility and severity of EV71 HFMD in Chinese Han populations, acting as a functional polymorphism by regulating ISGs expression, such as OAS1 and MX1.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zou</LastName><ForeName>Rongrong</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Shenzhen Third People's Hospital, University of South China, Shenzhen, 518112, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Guangdong Key Laboratory of Infectious Diseases, Shenzhen Third People's Hospital, Guangdong Medical College, Shenzhen, 518112, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Guoliang</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Guangdong Key Laboratory of Infectious Diseases, Shenzhen Third People's Hospital, Guangdong Medical College, Shenzhen, 518112, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Shenzhen Key Laboratory of Pathogen and Immunity, Shenzhen Third People's Hospital, Shenzhen, 518112, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Shaoyuan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Guangdong Key Laboratory of Infectious Diseases, Shenzhen Third People's Hospital, Guangdong Medical College, Shenzhen, 518112, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Wenfei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Guangdong Key Laboratory of Infectious Diseases, Shenzhen Third People's Hospital, Guangdong Medical College, Shenzhen, 518112, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yuan</LastName><ForeName>Jing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Guangdong Key Laboratory of Infectious Diseases, Shenzhen Third People's Hospital, Guangdong Medical College, Shenzhen, 518112, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Jianming</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Guangdong Key Laboratory of Infectious Diseases, Shenzhen Third People's Hospital, Guangdong Medical College, Shenzhen, 518112, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yanrong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Guangdong Key Laboratory of Infectious Diseases, Shenzhen Third People's Hospital, Guangdong Medical College, Shenzhen, 518112, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Yimin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Guangdong Key Laboratory of Infectious Diseases, Shenzhen Third People's Hospital, Guangdong Medical College, Shenzhen, 518112, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deng</LastName><ForeName>Yong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Shenzhen Third People's Hospital, University of South China, Shenzhen, 518112, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Guangdong Key Laboratory of Infectious Diseases, Shenzhen Third People's Hospital, Guangdong Medical College, Shenzhen, 518112, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Boping</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Guangdong Key Laboratory of Infectious Diseases, Shenzhen Third People's Hospital, Guangdong Medical College, Shenzhen, 518112, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>George Fu</ForeName><Initials>GF</Initials><AffiliationInfo><Affiliation>Shenzhen Key Laboratory of Pathogen and Immunity, Shenzhen Third People's Hospital, Shenzhen, 518112, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Molecular Virology, CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, 100101, Beijing.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Yingxia</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Shenzhen Third People's Hospital, University of South China, Shenzhen, 518112, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Guangdong Key Laboratory of Infectious Diseases, Shenzhen Third People's Hospital, Guangdong Medical College, Shenzhen, 518112, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Shenzhen Key Laboratory of Pathogen and Immunity, Shenzhen Third People's Hospital, Shenzhen, 518112, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>12</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C507964">IFNAR1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C579071">MX1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D064547">Myxovirus Resistance Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>156986-95-7</RegistryNumber><NameOfSubstance UI="D053633">Receptor, Interferon alpha-beta</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.7.-</RegistryNumber><NameOfSubstance UI="C475085">OAS1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.7.84</RegistryNumber><NameOfSubstance UI="D015088">2',5'-Oligoadenylate Synthetase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D015088" MajorTopicYN="N">2',5'-Oligoadenylate Synthetase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000483" MajorTopicYN="N">Alleles</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N">China</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="Y">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005838" MajorTopicYN="N">Genotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006232" MajorTopicYN="N">Hand, Foot and Mouth Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007963" MajorTopicYN="N">Leukocytes, Mononuclear</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064547" MajorTopicYN="N">Myxovirus Resistance Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="Y">Polymorphism, Single Nucleotide</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011401" MajorTopicYN="N">Promoter Regions, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053633" MajorTopicYN="N">Receptor, Interferon alpha-beta</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059467" MajorTopicYN="N">Transcriptome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>5</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>11</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>12</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>12</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>11</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2015</Year><Month>12</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26679744</ArticleId><ArticleId IdType="pmc">PMC4683517</ArticleId><ArticleId IdType="doi">10.1038/srep18541</ArticleId><ArticleId IdType="pii">srep18541</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zhu F. C. et al. Retrospective study of the incidence of HFMD and seroepidemiology of antibodies against EV71 and CoxA16 in prenatal women and their infants. PLoS One 7, e37206 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3360679</ArticleId><ArticleId IdType="pubmed">22662137</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang F. et al. Survey of enterovirus infections from hand, foot and mouth disease outbreak in China, 2009. Virol J 8, 508 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3227625</ArticleId><ArticleId IdType="pubmed">22054534</ArticleId></ArticleIdList></Reference><Reference><Citation>Ni H. et al. Epidemiological and etiological characteristics of hand, foot, and mouth disease in Ningbo, China, 2008-2011. J Clin Virol 54, 342&#x2013;8 (2012).</Citation><ArticleIdList><ArticleId IdType="pubmed">22652041</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan L. G. et al. Deaths of children during an outbreak of hand, foot, and mouth disease in sarawak, malaysia: clinical and pathological characteristics of the disease. For the Outbreak Study Group. Clin Infect Dis 31, 678&#x2013;83 (2000).</Citation><ArticleIdList><ArticleId IdType="pubmed">11017815</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S. M. et al. Pathogenesis of enterovirus 71 brainstem encephalitis in pediatric patients: roles of cytokines and cellular immune activation in patients with pulmonary edema. J Infect Dis 188, 564&#x2013;70 (2003).</Citation><ArticleIdList><ArticleId IdType="pubmed">12898444</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S. M. et al. Clinical spectrum of enterovirus 71 infection in children in southern Taiwan, with an emphasis on neurological complications. Clin Infect Dis 29, 184&#x2013;90 (1999).</Citation><ArticleIdList><ArticleId IdType="pubmed">10433583</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan X. et al. The persistent circulation of enterovirus 71 in People&#x2019;s Republic of China: causing emerging nationwide epidemics since 2008. PLoS One 6, e25662 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3181342</ArticleId><ArticleId IdType="pubmed">21980521</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu J. Enterovirus 71 infection: a new threat to global public health? Lancet Neurol 7, 868&#x2013;9 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7128195</ArticleId><ArticleId IdType="pubmed">18848307</ArticleId></ArticleIdList></Reference><Reference><Citation>National Health and Family Planning Commission of the People&#x2019;s Republic of China. Ministry of Health released the National Notifiable Infectious Diseases Overview of January 2012 and 2011. Epidemic information. (2012) Available at: http://www.moh.gov.cn/wsb/pyqxx/201202/54106.shtml. (Accessed: 10th February 2012).</Citation></Reference><Reference><Citation>Ahmad K. Hand, foot, and mouth disease outbreak reported in Singapore. Lancet 356, 1338 (2000).</Citation><ArticleIdList><ArticleId IdType="pubmed">11073035</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho M. et al. An epidemic of enterovirus 71 infection in Taiwan. Taiwan Enterovirus Epidemic Working Group. N Engl J Med 341, 929&#x2013;35 (1999).</Citation><ArticleIdList><ArticleId IdType="pubmed">10498487</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang F. et al. Enterovirus 71 outbreak in the People&#x2019;s Republic of China in 2008. J Clin Microbiol 47, 2351&#x2013;2 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2708525</ArticleId><ArticleId IdType="pubmed">19439545</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y. et al. An emerging recombinant human enterovirus 71 responsible for the 2008 outbreak of hand foot and mouth disease in Fuyang city of China. Virol J 7, 94 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2885340</ArticleId><ArticleId IdType="pubmed">20459851</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu W. et al. Distribution of enteroviruses in hospitalized children with hand, foot and mouth disease and relationship between pathogens and nervous system complications. Virol J 9, 8 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3268717</ArticleId><ArticleId IdType="pubmed">22230340</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang L. Y. et al. Neurodevelopment and cognition in children after enterovirus 71 infection. N Engl J Med 356, 1226&#x2013;34 (2007).</Citation><ArticleIdList><ArticleId IdType="pubmed">17377160</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C. C. et al. Neurologic complications in children with enterovirus 71 infection. N Engl J Med 341, 936&#x2013;42 (1999).</Citation><ArticleIdList><ArticleId IdType="pubmed">10498488</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng K. F., Chen L. L., Huang P. N. &amp; Shih S. R. Neural pathogenesis of enterovirus 71 infection. Microbes Infect 12, 505&#x2013;10 (2010).</Citation><ArticleIdList><ArticleId IdType="pubmed">20348010</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X. et al. Association of functional polymorphisms in the MxA gene with susceptibility to enterovirus 71 infection. Hum Genet 133, 187&#x2013;97 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7088390</ArticleId><ArticleId IdType="pubmed">24085612</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai Y. et al. Association analysis of polymorphisms in OAS1 with susceptibility and severity of hand, foot and mouth disease. Int J Immunogenet 41, 384&#x2013;92 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">25059424</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J., Chen Z. Z., Lv T. G., Liu P. P. &amp; Chen Z. B. Association of IP-10 gene polymorphism with susceptibility to Enterovirus 71 infection. Biomed Rep 1, 410&#x2013;412 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3917089</ArticleId><ArticleId IdType="pubmed">24648959</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J. et al. Association of interleukin 10 and interferon gamma gene polymorphisms with enterovirus 71 encephalitis in patients with hand, foot and mouth disease. Scand J Infect Dis 44, 465&#x2013;9 (2012).</Citation><ArticleIdList><ArticleId IdType="pubmed">22263663</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J. A., Chen Z. B., Lv T. G., Han Z. L. &amp; Liu P. P. Impact of endothelial nitric oxide synthase gene polymorphism on severity of enterovirus 71-infection in Chinese children. Clin Biochem 46, 1842&#x2013;7 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">24140479</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J. A., Chen Z. B., Lv T. G. &amp; Han Z. L. Genetic polymorphism of CCL2-2518, CXCL10-201, IL8+781 and susceptibility to severity of Enterovirus-71 infection in a Chinese population. Inflamm Res 63, 549&#x2013;56 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">24609754</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoneyama M. et al. Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity. J Immunol 175, 2851&#x2013;8 (2005).</Citation><ArticleIdList><ArticleId IdType="pubmed">16116171</ArticleId></ArticleIdList></Reference><Reference><Citation>Cleary C. M., Donnelly R. J., Soh J., Mariano T. M. &amp; Pestka S. Knockout and reconstitution of a functional human type I interferon receptor complex. J Biol Chem 269, 18747&#x2013;9 (1994).</Citation><ArticleIdList><ArticleId IdType="pubmed">8034627</ArticleId></ArticleIdList></Reference><Reference><Citation>Novick D., Cohen B. &amp; Rubinstein M. The human interferon alpha/beta receptor: characterization and molecular cloning. Cell 77, 391&#x2013;400 (1994).</Citation><ArticleIdList><ArticleId IdType="pubmed">8181059</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia M. A. et al. Impact of protein kinase PKR in cell biology: from antiviral to antiproliferative action. Microbiol Mol Biol Rev 70, 1032&#x2013;60 (2006).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1698511</ArticleId><ArticleId IdType="pubmed">17158706</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams B. R. PKR; a sentinel kinase for cellular stress. Oncogene 18, 6112&#x2013;20 (1999).</Citation><ArticleIdList><ArticleId IdType="pubmed">10557102</ArticleId></ArticleIdList></Reference><Reference><Citation>Silverman R. H. Fascination with 2-5A-dependent RNase: a unique enzyme that functions in interferon action. J Interferon Res 14, 101&#x2013;4 (1994).</Citation><ArticleIdList><ArticleId IdType="pubmed">7523539</ArticleId></ArticleIdList></Reference><Reference><Citation>Haller O. &amp; Kochs G. Interferon-induced mx proteins: dynamin-like GTPases with antiviral activity. Traffic 3, 710&#x2013;7 (2002).</Citation><ArticleIdList><ArticleId IdType="pubmed">12230469</ArticleId></ArticleIdList></Reference><Reference><Citation>Goodbourn S., Didcock L. &amp; Randall R. E. Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures. J Gen Virol 81, 2341&#x2013;64 (2000).</Citation><ArticleIdList><ArticleId IdType="pubmed">10993923</ArticleId></ArticleIdList></Reference><Reference><Citation>George C. X. et al. Tipping the balance: antagonism of PKR kinase and ADAR1 deaminase functions by virus gene products. J Interferon Cytokine Res 29, 477&#x2013;87 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2956706</ArticleId><ArticleId IdType="pubmed">19715457</ArticleId></ArticleIdList></Reference><Reference><Citation>Toth A. M., Li Z., Cattaneo R. &amp; Samuel C. E. RNA-specific adenosine deaminase ADAR1 suppresses measles virus-induced apoptosis and activation of protein kinase PKR. J Biol Chem 284, 29350&#x2013;6 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2785566</ArticleId><ArticleId IdType="pubmed">19710021</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu J. et al. Enterovirus 71 disrupts interferon signaling by reducing the level of interferon receptor 1. J Virol 86, 3767&#x2013;76 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3302529</ArticleId><ArticleId IdType="pubmed">22258259</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y. et al. Enterovirus 71 inhibits cellular type I interferon signaling by downregulating JAK1 protein expression. Viral Immunol 27, 267&#x2013;76 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">24905060</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou J. et al. A non-synonymous single nucleotide polymorphism in IFNAR1 affects susceptibility to chronic hepatitis B virus infection. J Viral Hepat 16, 45&#x2013;52 (2009).</Citation><ArticleIdList><ArticleId IdType="pubmed">18761606</ArticleId></ArticleIdList></Reference><Reference><Citation>He X. X. et al. Persistent effect of IFNAR-1 genetic polymorphism on the long-term pathogenesis of chronic HBV infection. Viral Immunol 23, 251&#x2013;7 (2010).</Citation><ArticleIdList><ArticleId IdType="pubmed">20565290</ArticleId></ArticleIdList></Reference><Reference><Citation>Diop G. et al. Exhaustive genotyping of the interferon alpha receptor 1 (IFNAR1) gene and association of an IFNAR1 protein variant with AIDS progression or susceptibility to HIV-1 infection in a French AIDS cohort. Biomed Pharmacother 60, 569&#x2013;77 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">17027223</ArticleId></ArticleIdList></Reference><Reference><Citation>van Pesch V., Lanaya H., Renauld J. C. &amp; Michiels T. Characterization of the murine alpha interferon gene family. J Virol 78, 8219&#x2013;28 (2004).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC446145</ArticleId><ArticleId IdType="pubmed">15254193</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts R. M., Ezashi T., Rosenfeld C. S., Ealy A. D. &amp; Kubisch H. M. Evolution of the interferon tau genes and their promoters, and maternal-trophoblast interactions in control of their expression. Reprod Suppl 61, 239&#x2013;51 (2003).</Citation><ArticleIdList><ArticleId IdType="pubmed">14635939</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy D. E. &amp; Darnell J. E. Jr. Stats: transcriptional control and biological impact. Nat Rev Mol Cell Biol 3, 651&#x2013;62 (2002).</Citation><ArticleIdList><ArticleId IdType="pubmed">12209125</ArticleId></ArticleIdList></Reference><Reference><Citation>de Veer M. J. et al. Functional classification of interferon-stimulated genes identified using microarrays. J Leukoc Biol 69, 912&#x2013;20 (2001).</Citation><ArticleIdList><ArticleId IdType="pubmed">11404376</ArticleId></ArticleIdList></Reference><Reference><Citation>Der S. D., Zhou A., Williams B. R. &amp; Silverman R. H. Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. Proc Natl Acad Sci USA 95, 15623&#x2013;8 (1998).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC28094</ArticleId><ArticleId IdType="pubmed">9861020</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasaki O., Karaki T. &amp; Imanishi J. Protective effect of interferon on infections with hand, foot, and mouth disease virus in newborn mice. J Infect Dis 153, 498&#x2013;502 (1986).</Citation><ArticleIdList><ArticleId IdType="pubmed">3005425</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu M. L. et al. Type I interferons protect mice against enterovirus 71 infection. J Gen Virol 86, 3263&#x2013;9 (2005).</Citation><ArticleIdList><ArticleId IdType="pubmed">16298971</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S., Yang Y., Xu J., Su L. &amp; Wang W. Effect of all-trans-retinoic acid on enterovirus 71 infection in vitro. Br J Nutr 111, 1586&#x2013;93 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">24495389</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang B. et al. Enterovirus 71 protease 2Apro targets MAVS to inhibit anti-viral type I interferon responses. PLoS Pathog 9, e1003231 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3605153</ArticleId><ArticleId IdType="pubmed">23555247</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei X. et al. The 3C protein of enterovirus 71 inhibits retinoid acid-inducible gene I-mediated interferon regulatory factor 3 activation and type I interferon responses. J Virol 84, 8051&#x2013;61 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2916543</ArticleId><ArticleId IdType="pubmed">20519382</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee Y. P., Wang Y. F., Wang J. R., Huang S. W. &amp; Yu C. K. Enterovirus 71 blocks selectively type I interferon production through the 3C viral protein in mice. J Med Virol 84, 1779&#x2013;89 (2012).</Citation><ArticleIdList><ArticleId IdType="pubmed">22997081</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou J. et al. Polymorphisms of type I interferon receptor 1 promoter and their effects on chronic hepatitis B virus infection. J Hepatol 46, 198&#x2013;205 (2007).</Citation><ArticleIdList><ArticleId IdType="pubmed">17125879</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanchan K. et al. Interferon-gamma (IFNG) microsatellite repeat and single nucleotide polymorphism haplotypes of IFN-alpha receptor (IFNAR1) associated with enhanced malaria susceptibility in Indian populations. Infect Genet Evol 29, 6&#x2013;14 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">25445652</ArticleId></ArticleIdList></Reference><Reference><Citation>Rifai M. A. &amp; Sabouni M. A. Utilizing genomic polymorphisms to personalize hepatitis C therapies. Curr Opin Organ Transplant 17, 198&#x2013;203 (2012).</Citation><ArticleIdList><ArticleId IdType="pubmed">22414802</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou J. et al. Functional dissection of an IFN-alpha/beta receptor 1 promoter variant that confers higher risk to chronic hepatitis B virus infection. J Hepatol 51, 322&#x2013;32 (2009).</Citation><ArticleIdList><ArticleId IdType="pubmed">19501422</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J. et al. Epidemiological analysis, detection, and comparison of space-time patterns of Beijing hand-foot-mouth disease (2008&#x2013;2012). PLoS One 9, e92745 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3963949</ArticleId><ArticleId IdType="pubmed">24663329</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X. et al. CD4 (+) CD25 (+) FoxP3 (+) regulatory T cells suppress Mycobacterium tuberculosis immunity in patients with active disease. Clin Immunol 123, 50&#x2013;9 (2007).</Citation><ArticleIdList><ArticleId IdType="pubmed">17234458</ArticleId></ArticleIdList></Reference><Reference><Citation>Vallittu A. M., Eralinna J. P., Ilonen J., Salmi A. A. &amp; Waris M. MxA protein assay for optimal monitoring of IFN-beta bioactivity in the treatment of MS patients. Acta Neurol Scand 118, 12&#x2013;7 (2008).</Citation><ArticleIdList><ArticleId IdType="pubmed">18081914</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>